Out of over 200+ marijuana stocks, here are 5 of the biggest marijuana stock winners in trading on Tuesday, April 3rd including GW Pharmaceuticals Plc. (NASDAQ:GWPH) and more...

Axim Biotechnologies, Inc. (OTC:AXIM)

Shares of Axim Biotechnologies, Inc. rose 9.59% on lower than average trading volume on the OTC markets, closing the day at $4.00 USD per share. Recently, AXIM entered into a binding distribution agreement for its proprietary cannabinoid-based nutraceutical chewing gum product, CanChew+.

GW Pharmaceuticals Plc. (NASDAQ:GWPH)

Shares of GW Pharmaceuticals Plc. rose 5.39% on higher than average trading volume on the NASDAQ, closing the day at $111.57 USD per share. Recently, GW Pharma received Notices of Allowance from the U.S. Patent and Trademark Office for five new Epidiolex patent applications.

Insys Therapeutics Inc. (NASDAQ:INSY)

Shares of Insys Therapeutics Inc. rose 7.38% on lower than average trading volume on the NASDAQ, closing the day at $6.40 USD per share. Yesterday, Insys announced the appointment of Trudy Vanhove as a new independent member of its Board of Directors. Given her extensive experience in clinical development and medical affairs, Dr. Vanhove will also serve on the Board’s R&D committee.

Marrone Bio Innovations, Inc. (OTC:MBII)

Shares of Marrone Bio Innovations, Inc. rose 14.22% on higher than average trading volume on the NASDAQ, closing the day at $2.49 USD per share. Yesterday, Marrone Bio Innovations announced that management is scheduled to present at The MicroCap Conference in New York City. The conference is being held on April 9-10, 2018 at the JW Marriott Essex House.

Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE)

Shares of Zynerba Pharmaceuticals, Inc. rose 14.16% on higher than average trading volume on the NASDAQ, closing the day at $9.11 USD per share. Recently, Zynerba announced that researchers at The Scripps Research Institute and the University of Maryland have generated preclinical data from a study funded by NIH grants that suggest potential value in using Zynerba's transdermal CBD to reduce the risk of relapse among recovering drug and alcohol addicts.

Tell us which marijuana stocks put you in the green today! Join the conversation in our Marijuana Stock Forum!

Conclusion

Find more about today's gainers by checking out their respective profiles in our global marijuana stock database via the linked tickers above. To stay up to date with important developments in the cannabis industry, be sure to subscribe to one or more of our free email newsletters. Also, connect with The Daily Marijuana Observer on Facebook, Twitter, StockTwits and Instagram!

D/M/O

Disclaimer

Investing in nanocap, microcap, and small cap stocks is highly speculative. The publishers of DailyMarijuanaObserver.com are not registered as Investment Advisors or Broker-Dealers in any jurisdiction whatsoever. The information contained on DailyMarijuanaObserver.com (“this site”) has been prepared solely for informational purposes. Nothing on the site is an offer or solicitation to buy or sell securities. Investors should seek financial advice regarding the appropriateness of investing in any securities mentioned from their financial advisor.